Drug General Information (ID: DDIC5F7JHZ)
Drug Name			Triamterene		Drug Info		Danaparoid		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Diuretics				Anticoagulants

Mechanism of Triamterene-Danaparoid Interaction (Severity Level: Moderate)
Increased risk of hyperkalemia Click to Show/Hide Mechanism Graph
Drug Name		Triamterene				Danaparoid
Mechanism		Hyperkalemia				Hyperkalemia
Key Mechanism Factor 1
		Factor Name		Hyperkalemia
		Factor Description		Hyperkalemia is a condition in which the level of potassium in the blood is higher than normal. While mild cases may not produce symptoms, severe hyperkalemia can lead to fatal arrhythmias if left untreated.
Mechanism Description		Increased risk of hyperkalemia by the combination of Triamterene and Danaparoid

Recommended Action
Management		Caution is advised if potassium-sparing diuretics are used with heparin or low molecular weight heparin. Serum potassium levels and renal function should be checked regularly.

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	Cerner Multum, Inc. "Australian Product Information.".
3	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".